eXoZymes, Inc. (EXOZ)
- Previous Close
11.25 - Open
11.40 - Bid 10.39 x 200
- Ask 10.47 x 100
- Day's Range
10.47 - 11.40 - 52 Week Range
8.50 - 23.99 - Volume
5,324 - Avg. Volume
14,424 - Market Cap (intraday)
87.611M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.89 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.
www.invizyne.comRecent News: EXOZ
View More
Performance Overview: EXOZ
Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EXOZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EXOZ
View MoreValuation Measures
Market Cap
90.71M
Enterprise Value
82.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
8.70
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-44.69%
Return on Equity (ttm)
-116.80%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-5.86M
Diluted EPS (ttm)
-0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
9.72M
Total Debt/Equity (mrq)
13.31%
Levered Free Cash Flow (ttm)
-2.75M